The Covid-19 vaccine script that TV shows are using to fight fear and misinformation
As doctors and health professionals race against Covid-19 vaccination skepticism, some Hollywood producers, writers and showrunners are betting that inputting vaccines into television storylines can help curb widespread misinformation.Source: CNBC
Yale Cancer Center Partners in Fight to Help Eliminate HPV-related Cancers
Yale Cancer Center joins the Association of American Cancer Institutes (AACI) and its partner organizations to endorse a Call to Action for our nation to work together toward the elimination of human papillomavirus (HPV)-related cancers.
Opportunities to vaccinate young women against HPV missed at alarming rate
en aged 18-26 who were eligible to receive Human Papilloma Virus (HPV) vaccine have missed at least one opportunity to receive the vaccine during a visit to an obstetrics and gynecology clinic, Yale researchers report. This study also confirms previous research showing racial disparities in vaccination for HPV: Women who identify as black are 61% more likely have had a missed opportunity than women who identify as white. These findings are published in the American Journal of Obstetrics and Gynecology. HPV is a well-known cause of pre-cancerous cervical lesions, which, if untreated, could develop into cervical cancer. Immunization against HPV has been shown to be safe and effective in preventing these pre-cancerous lesions. The two-dose HPV vaccine is recommended for administration to It is recommended that girls ages 11-12 receive the two-dose HPV vaccine, and that those through age 26 receive the three-dose vaccination for “catch-up.”
$1.8 Million Granted to Yale School of Public Health to Study Effectiveness of HPV Vaccine
A $1.8 million National Institutes of Health grant will help researchers at the Yale School of Public Health shed light on the real-world effectiveness of the Human Papillomavirus (HPV) vaccine. Results of this study can ultimately help to maximize the vaccine’s impact on several types of cancer.
Precancerous Lesions Associated with HPV Dropping in Connecticut, YSPH Study Finds
The vaccine for the Human Papillomavirus (HPV) is proving to have significant population-level effects in Connecticut, with rates of precancerous lesions caused by HPV down drastically among young women, a new Yale School of Public Health study finds.
‘Tripledemic’ Rages On: Fever-Filled Weeks Lie Ahead
New, immune evasive versions of the Omicron variant are spreading, and Covid-19 cases, hospitalizations and deaths are once again rising, although the figures remain far below last winter’s peak. But this year the coronavirus has company: Common seasonal viruses, which lay low for the last two winters, have come roaring back.Source: The New York Times
Health Headlines: Rise in COVID cases, expanded bivalent booster eligibility
In today’s health headlines, Connecticut is seeing a steep rise in COVID cases, bivalent COVID booster eligibility has been expanded, and the World Health Organization has warned about a rise in Strep A cases. Dr. Jessica Tuan, a Yale infectious diseases doctor, clinical trialist, and instructor at Yale School of Medicine, joins Lisa Carberg on News 8 at Noon to talk about these issues.Source: WTNH News 8
Yale Internal Medicine Faculty Partner with Formerly Incarcerated Leaders to Obtain R01
The COVID-19 pandemic has had a disproportionate impact on many people in underserved communities, including those who are incarcerated or work in our nation’s prison systems. Infections across this community have been five times higher than in the general U.S. population. Surrounding communities have also been disproportionately affected.
Covid-19 vaccines have saved more than 3 million lives in US, study says, but the fight isn’t over
The Covid-19 vaccines have kept more than 18.5 million people in the US out of the hospital and saved more than 3.2 million lives, a new study says – and that estimate is most likely a conservative one, the researchers say.Source: CNN
Health Headlines: How to tell the difference between RSV and the flu
RSV and the flu are both circulating. How to tell the difference? Flu hospitalizations are doubling week over week, and a shortage in primary care physicians is affecting care this flu season. Dr. Arjun Venkatesh, chief of emergency medicine administration at Yale Medicine and associate professor at Yale School of Medicine, shares what you need to know.Source: WTNH